Td Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 330,067 shares of REGN stock, worth $250 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
330,067
Previous 351,545 6.11%
Holding current value
$250 Million
Previous $369 Million 6.09%
% of portfolio
0.32%
Previous 0.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$1024.09 - $1201.76 $22 Million - $25.8 Million
-21,478 Reduced 6.11%
330,067 $347 Million
Q2 2024

Aug 02, 2024
BUY
$883.2 - $1071.19 $72.5 Million - $87.9 Million
82,034 Added 30.44%
351,545 $369 Million
Q1 2024

May 08, 2024
BUY
$902.69 - $993.35 $151 Million - $166 Million
166,998 Added 162.9%
269,511 $259 Million
Q4 2023

Feb 12, 2024
SELL
$775.18 - $881.7 $60.3 Million - $68.6 Million
-77,754 Reduced 43.13%
102,513 $90 Million
Q3 2023

Oct 27, 2023
BUY
$692.45 - $844.37 $48.9 Million - $59.6 Million
70,628 Added 64.42%
180,267 $148 Million
Q2 2023

Aug 09, 2023
SELL
$700.03 - $830.35 $1.75 Million - $2.07 Million
-2,495 Reduced 2.23%
109,639 $78.8 Million
Q1 2023

May 10, 2023
BUY
$680.49 - $826.97 $6.44 Million - $7.83 Million
9,469 Added 9.22%
112,134 $92.1 Million
Q4 2022

Feb 06, 2023
BUY
$705.89 - $766.39 $7.29 Million - $7.91 Million
10,323 Added 11.18%
102,665 $74.1 Million
Q3 2022

Nov 07, 2022
BUY
$573.97 - $724.32 $2.9 Million - $3.66 Million
5,048 Added 5.78%
92,342 $63.9 Million
Q2 2022

Aug 04, 2022
BUY
$548.35 - $738.84 $3.21 Million - $4.33 Million
5,855 Added 7.19%
87,294 $51.6 Million
Q1 2022

May 10, 2022
SELL
$595.12 - $698.43 $120,809 - $141,781
-203 Reduced 0.25%
81,439 $56.9 Million
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $888,046 - $1.1 Million
1,634 Added 2.04%
81,642 $51.6 Million
Q3 2021

Nov 09, 2021
SELL
$574.03 - $680.96 $447,743 - $531,148
-780 Reduced 0.97%
80,008 $48.4 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $994,771 - $1.18 Million
2,104 Added 2.67%
80,788 $46.4 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $1.26 Million - $1.55 Million
2,826 Added 3.73%
78,684 $37.2 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $548,131 - $696,745
1,146 Added 1.53%
75,858 $36.6 Million
Q3 2020

Nov 10, 2020
BUY
$544.75 - $658.21 $2.86 Million - $3.46 Million
5,258 Added 7.57%
74,712 $41.8 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $4.09 Million - $5.34 Million
8,290 Added 13.55%
69,454 $43.3 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $2.91 Million - $4.28 Million
8,665 Added 16.51%
61,164 $29.9 Million
Q4 2019

Feb 11, 2020
SELL
$274.13 - $376.51 $1.61 Million - $2.21 Million
-5,867 Reduced 10.05%
52,499 $19.7 Million
Q3 2019

Nov 07, 2019
BUY
$273.46 - $318.39 $452,576 - $526,935
1,655 Added 2.92%
58,366 $16.2 Million
Q2 2019

Aug 01, 2019
SELL
$299.6 - $414.82 $3.27 Million - $4.53 Million
-10,910 Reduced 16.13%
56,711 $17.8 Million
Q1 2019

May 08, 2019
BUY
$372.08 - $439.57 $7.28 Million - $8.6 Million
19,567 Added 40.72%
67,621 $27.8 Million
Q4 2018

Feb 01, 2019
BUY
$335.82 - $403.04 $772,050 - $926,588
2,299 Added 5.02%
48,054 $17.9 Million
Q3 2018

Nov 01, 2018
SELL
$351.14 - $408.51 $1.4 Million - $1.63 Million
-3,988 Reduced 8.02%
45,755 $18.5 Million
Q2 2018

Jul 31, 2018
BUY
$284.6 - $344.99 $465,036 - $563,713
1,634 Added 3.4%
49,743 $17.2 Million
Q1 2018

May 11, 2018
SELL
$315.82 - $393.78 $121,590 - $151,605
-385 Reduced 0.79%
48,109 $16.6 Million
Q4 2017

Feb 02, 2018
SELL
$358.63 - $469.95 $54,870 - $71,902
-153 Reduced 0.31%
48,494 $18.2 Million
Q3 2017

Nov 09, 2017
BUY
$431.38 - $504.0 $21 Million - $24.5 Million
48,647
48,647 $21.8 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email